GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CHA Vaccine Research Institute Co Ltd (XKRX:261780) » Definitions » Debt-to-Asset

CHA Vaccine Research Institute Co (XKRX:261780) Debt-to-Asset : 0.20 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is CHA Vaccine Research Institute Co Debt-to-Asset?

CHA Vaccine Research Institute Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩4,958.5 Mil. CHA Vaccine Research Institute Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩4,630.7 Mil. CHA Vaccine Research Institute Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₩47,248.0 Mil. CHA Vaccine Research Institute Co's debt to asset for the quarter that ended in Dec. 2024 was 0.20.


CHA Vaccine Research Institute Co Debt-to-Asset Historical Data

The historical data trend for CHA Vaccine Research Institute Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHA Vaccine Research Institute Co Debt-to-Asset Chart

CHA Vaccine Research Institute Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial 0.73 0.32 0.39 0.10 0.20

CHA Vaccine Research Institute Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.10 0.12 0.19 0.20

Competitive Comparison of CHA Vaccine Research Institute Co's Debt-to-Asset

For the Biotechnology subindustry, CHA Vaccine Research Institute Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CHA Vaccine Research Institute Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CHA Vaccine Research Institute Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where CHA Vaccine Research Institute Co's Debt-to-Asset falls into.



CHA Vaccine Research Institute Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

CHA Vaccine Research Institute Co's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(4958.457 + 4630.711) / 47248.002
=0.20

CHA Vaccine Research Institute Co's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(4958.457 + 4630.711) / 47248.002
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHA Vaccine Research Institute Co  (XKRX:261780) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


CHA Vaccine Research Institute Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of CHA Vaccine Research Institute Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CHA Vaccine Research Institute Co Business Description

Traded in Other Exchanges
N/A
Address
560 Dunchon-daero, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13230
CHA Vaccine Research Institute Co Ltd is a research-oriented biotechnology company. It researches and develops a broad range of vaccine products targeting infectious disease as well as chronic disease.

CHA Vaccine Research Institute Co Headlines

No Headlines